Matthew Jordan Klebanoff, MD
Hospital Medicine
Accepting new patients
Sees patients age 18 and up
Penn Hospital Medicine HUP
Penn Medicine Provider
About me
- Assistant Professor of Medicine (General Internal Medicine)
My education and training
- Yale University School of MedicineMedical School
- Hospital of the University of PennsylvaniaResidency
Spoken languages
English
English
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
- Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Klebanoff is a Penn Medicine physician.
Qualifications and experience
- Internal Medicine, 2023
- AcademyHealth, National
- Society of General Internal Medicine, National
- The Obesity Society, National
Treatments and conditions
Research
Publications
Klebanoff MJ, Li P, Long JA, Doshi JA Medicare Part D Coverage and Costs for Glucagon-Like Peptide-1 Receptor Agonists. , JAMA., 334(20): 2025,1848-1850
Klebanoff MJ, Chetty AK, Doshi JA Medicaid Coverage and Prior Authorization for Antiobesity Glucagon-Like Peptide-1 Receptor Agonists: A Cross-Sectional Study of State Policies. , J Gen Intern Med.: 2025,(Online ahead of print)
Li P, Lin JK, Klebanoff MJ, Palkar R, Chahin S, Doshi JA Reducing the Out-of-Pocket Costs of Disease-Modifying Therapies for Medicare Beneficiaries With Multiple Sclerosis. , Neurol Clin Pract., 15(6): 2025,e200536
Doshi JA, Li P, Klebanoff MJ, Lin JK Inflation Reduction Act Provisions and Medicare Part D Out-of-Pocket Costs for Specialty Drugs. , JAMA Health Forum., 6(5): 2025
Klebanoff MJ, Chetty AK, Doshi JA Prior Authorization Policies for Antiobesity GLP-1 Agonists across State Medicaid Programs. , Society of General Internal Medicine Annual Meeting.: 2025
Klebanoff MJ, Li P, JA Long, Doshi JA Trends in Medicare Part D Formulary Coverage, Prior Authorization, and Out-of-Pocket Costs for Glucagon-like Peptide-1 Receptor Agonists, 2020-2025. , AcademyHealth Annual Research Meeting (Podium Presentation).: 2025
Klebanoff MJ, Li P, Chatterjee P, Doshi JA Real-time Prescription Benefit Tool Adoption Among U.S. Hospitals. , JAMA Health Forum., 5(10): 2024,e243181
Klebanoff MJ, Li P, Lin JK, Doshi JA Formulary Coverage of Brand-Name Adalimumab and Biosimilars Across Medicare Part D Plans. , JAMA., 332(1): 2024,74-76
Klebanoff MJ, Chetty AK, Doshi JA Prior Authorization Policies for Antiobesity GLP-1 Agonists across State Medicaid Programs. , National Clinician Scholars Program Annual Meeting (Podium Presentation).: 2024
Klebanoff MJ, Li P, Chatterjee P, Doshi JA Characteristics of hospitals with real-time prescription benefit tools. , Society of General Internal Medicine Annual Meeting.: 2024